Olian Judy D. 4

What Happened

• Judy D. Olian, a director of United Therapeutics Corporation (NASDAQ: UTHR), sold 200 shares of common stock on March 23, 2026.
• The shares were sold at $530.00 per share for a total of $106,000. The filing indicates this was a sale (S) executed under a pre-arranged 10b5-1 trading plan.

Key Details

• Transaction date and price: March 23, 2026 — 200 shares at $530.00 each.
• Total proceeds: $106,000.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: The sale was made pursuant to a 10b5-1 plan established by the reporting person on November 4, 2025.
• Filing timing: Transaction reported in an Form 4 filed March 24, 2026 for the March 23 trade (no indication of a late-file designation in the provided data).

Context

• A 10b5-1 plan is a pre-arranged trading program that lets insiders sell shares on a set schedule or according to preset rules; such sales are often routine and do not necessarily reflect the insider’s current view of the company.
• For retail investors: sales by directors can be for many personal or diversification reasons. Purchases typically carry more weight as bullish signals; this single, planned sale should be viewed as a routine insider disposition unless accompanied by other significant insider activity.